PeerView Internal Medicine CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇵🇱PL · Science#109500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
150 to 900🎙 Daily cadence·677 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇵🇱100% - Active Followers
Loyal subscribers who consistently listen
200 to 1.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Not detected.
Recent guests
Recent episodes
Colleen F. Kelley, MD, MPH - Long-Acting PrEP for Diverse Frontline Providers in an Evolving Prevention Landscape
Jun 15, 2026
Unknown duration
Jordan Mast, MMS, PA-C - Lighting the Way to Patient-Centered Alzheimer’s Care: Employing Amyloid-Targeting Therapies Safely and Effectively Through Careful Patient Selection and Shared Decision-Making
Jun 15, 2026
Unknown duration
Neal D. Shore, MD, FACS - Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care
Jun 15, 2026
Unknown duration
Amy M. Klingler, MS, PA-C, DFAAPA - Keeping Brain Health Top of Mind: Preserving Cognition and Improving Early Detection and Diagnosis of Alzheimer’s Disease
Jun 15, 2026
Unknown duration
Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice
May 29, 2026
37m 51s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/15/26 | Colleen F. Kelley, MD, MPH - Long-Acting PrEP for Diverse Frontline Providers in an Evolving Prevention Landscape | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YMS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 7, 2027.Long-Acting PrEP for Diverse Frontline Providers in an Evolving Prevention Landscape In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Gilead Sciences, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/15/26 | Jordan Mast, MMS, PA-C - Lighting the Way to Patient-Centered Alzheimer’s Care: Employing Amyloid-Targeting Therapies Safely and Effectively Through Careful Patient Selection and Shared Decision-Making | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/FUS865. CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE credit will be available until June 17, 2027.Lighting the Way to Patient-Centered Alzheimer’s Care: Employing Amyloid-Targeting Therapies Safely and Effectively Through Careful Patient Selection and Shared Decision-Making In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Gerontological Society of America. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/15/26 | Neal D. Shore, MD, FACS - Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/15/26 | Amy M. Klingler, MS, PA-C, DFAAPA - Keeping Brain Health Top of Mind: Preserving Cognition and Improving Early Detection and Diagnosis of Alzheimer’s Disease | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/QRA865. CME/MOC/NCPD/AAPA/ASWB-ACE/CDR/APA/IPCE credit will be available until June 15, 2027.Keeping Brain Health Top of Mind: Preserving Cognition and Improving Early Detection and Diagnosis of Alzheimer’s Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Gerontological Society of America. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 5/29/26 | Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice✨ | Acute Lymphoblastic LeukemiaBispecific Options+3 | Ibrahim Aldoss, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Acute Lymphoblastic Leukemiabispecific therapy+4 | AstraZeneca | 37m 51s | |
| 5/29/26 | Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients✨ | Asparaginase exposurePediatric treatment+4 | Luke Maese, DORachel Rau, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Asparaginasepediatric oncology+4 | Jazz Pharmaceuticals | 48m 37s | |
| 5/29/26 | Anna Chodos, MD, MPH - Getting Ahead of Cognitive Decline—Applying Patient-Centered Strategies to Assess and Reduce Dementia Risk in Primary Care: An AI-Guided Case Simulation Activity✨ | cognitive declinedementia risk+3 | Anna Chodos, MD, MPH | PVI, PeerView Institute for Medical EducationBrightFocus Foundation+3 | — | cognitive declinedementia+5 | Lilly | 46m 16s | |
| 5/29/26 | Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition✨ | InflammationFibrosis+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Inflammatory Bowel DiseaseTL1A Inhibition+4 | Merck & Co., Inc. | 1h 10m 58s | |
| 5/29/26 | Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings✨ | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Jaume Capdevila, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 54m 53s | |
| 5/29/26 | Adam Friedman, MD, FAAD - Wheals of Fortune: Chronic Spontaneous Urticaria Challenges and the Road to Resolution✨ | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/25/26 | Professor Frank Jessen, MD - AD/PD 2026: Advancing Alzheimer’s Disease Detection, Diagnosis, and Treatment Through New Evidence✨ | Alzheimer's DiseaseDetection+4 | Professor Frank Jessen, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseCME+5 | Lilly | 31m 48s | |
| 5/25/26 | Gerald Appel, MD / Ellie Kelepouris, MD, FACP, FAHA - IgA Nephropathy Evolved: Redefining Standards of Care Through Innovation and Evidence✨ | IgA NephropathyStandards of Care+3 | Gerald Appel, MDEllie Kelepouris, MD, FACP, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | IgA NephropathyCME+3 | Novartis Pharmaceuticals Corporation | 1h 02m 27s | |
| 5/12/26 | Julie L. Rosenthal, MD, FACC, Ronald Witteles, MD, FACC - Hidden in Plain Sight: Recognizing and Referring Patients With Transthyretin Cardiac Amyloidosis in Internal Medicine✨ | Transthyretin Cardiac AmyloidosisInternal Medicine+3 | Julie L. Rosenthal, MD, FACCRonald Witteles, MD, FACC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Transthyretin Cardiac Amyloidosisinternal medicine+5 | Alnylam Pharmaceuticals, Inc. | 59m 02s | |
| 5/12/26 | Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies✨ | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | retinal treatmentanti-VEGF+4 | Genentech | 35m 36s | |
| 5/7/26 | Christie M. Ballantyne, MD, FACP, FACC - Leveraging Recent Evidence on PCSK9 Inhibition: Strategies to Address Clinical Challenges for Meeting LDL-C Targets✨ | PCSK9 InhibitionLDL-C Targets+3 | Christie M. Ballantyne, MD, FACP, FACC | PVI, PeerView Institute for Medical EducationThe Mended Hearts, Inc. | Rahway, NJ, USA | PCSK9LDL-C+5 | Merck & Co., Inc. | 1h 22m 52s | |
| 5/7/26 | Unpacking Parkinson's Disease Psychosis: Rapid Detection and Management in Long-Term Care - Unpacking Parkinson's Disease Psychosis: Rapid Detection and Management in Long-Term Care✨ | Parkinson's DiseasePsychosis+3 | — | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | April 29, 2027 | Parkinson's Diseasepsychosis+5 | ACADIA Pharmaceuticals Inc. | 56m 47s | |
| 5/7/26 | Professor Christopher Chen, Professor Atsushi Iwata, MD, PhD - Strategies for Appropriate Assessment and Use of APOE Status in Alzheimer’s Disease: Clinical Care in the Asia-Pacific Region✨ | Alzheimer's DiseaseAPOE Status+4 | Professor Christopher ChenProfessor Atsushi Iwata, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | APOEAlzheimer's Disease+4 | Lilly | 45m 04s | |
| 5/7/26 | David Sabatino, PharmD, BCOP / Marie E. Sirek, PharmD, BCACP, CPP - B-Keepers: Pharmacist Principles for Effective BTK Targeting in CLL, MCL, and Other B-Cell Cancers✨ | pharmacist principlesBTK targeting+4 | David Sabatino, PharmD, BCOPMarie E. Sirek, PharmD, BCACP, CPP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | BTK inhibitorschronic lymphocytic leukemia+4 | AstraZeneca | 57m 33s | |
| 5/7/26 | Tiba Al Sagheer, PharmD, BCOP, BCACP, Amanda Yepes, PharmD, BCOP - Coordinating Transformative Care in NHL: Pharmacist Insights for Delivering CAR-T Therapy in the Era of Expanded Access and Therapeutic Innovation✨ | NHLCAR-T Therapy+4 | Tiba Al SagheerAmanda Yepes | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | NHLCAR-T Therapy+6 | Bristol Myers Squibb | 1h 00m 30s | |
| 5/7/26 | Jay H. Shubrook, DO, FAAFP, FACOFP - Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health✨ | incretin-based therapiestype 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretintype 2 diabetes+6 | Lilly | 1h 25m 04s | |
| 5/7/26 | J. Andrew Berkowski, MD, FAASM - Transforming Restless Legs Syndrome Management: Bridging Treatment Gaps With Updated Guidelines and Device-Integrated Solutions✨ | Restless Legs SyndromeTreatment Guidelines+3 | J. Andrew Berkowski, MD, FAASM | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Restless Legs Syndrometreatment gaps+3 | Noctrix Health, Inc. | 46m 37s | |
| 5/7/26 | April W. Armstrong, MD, MPH - A New Era in Psoriasis Care With Oral IL-23 Inhibitors✨ | Psoriasis careOral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | psoriasisIL-23 inhibitors+4 | Johnson & Johnson | 33m 41s | |
| 4/28/26 | Sarah Cuddy, MD / Vasvi Singh, MD, FACC, FASNC, FSCCT - Transthyretin Cardiac Amyloidosis: Integrating New Paradigms Into Cardiology Practice✨ | Transthyretin Cardiac AmyloidosisCardiology Practice+2 | Sarah Cuddy, MDVasvi Singh, MD, FACC, FASNC, FSCCT | PVI, PeerView Institute for Medical EducationThe Mended Hearts, Inc. | — | Transthyretin Cardiac AmyloidosisCardiology+3 | Alnylam Pharmaceuticals, Inc. | 1h 02m 41s | |
| 4/27/26 | Milind Desai, MD, MBA / Anjali Tiku Owens, MD - Cardiac Myosin Inhibition in the Real World: What Have We Learned From Long-Term Experience in Obstructive HCM?✨ | Cardiac Myosin InhibitionObstructive HCM+3 | Milind Desai, MD, MBAAnjali Tiku Owens, MD | PVI, PeerView Institute for Medical EducationThe Mended Hearts, Inc.+3 | — | Cardiac Myosin InhibitionObstructive HCM+4 | Bristol Myers Squibb | 59m 46s | |
| 4/27/26 | Sarah Hayward, PharmD, BCOP - Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/CKF865. CME/CPE/IPCE credit will be available until April 26, 2027.Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by independent medical education grants from AstraZeneca, GSK, and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation. | — | ||||||
Showing 25 of 704
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.